Importantly, pharmacological inhibition of mTOR or MEK lowered the abundance of PCNA, a marker of tumor cell proliferation, and subsequently suppressed cell growth and tumorigenesis in mouse model. The gene discussed is MAP2K7; the disease is neoplasm.